ClinicalTrials.Veeva

Menu

Registry of Acute Coronary Syndrome From University Hospital of Vigo (CardioCHUVI)

H

Hospital Álvaro Cunqueiro

Status

Unknown

Conditions

Acute Coronary Syndrome

Treatments

Drug: Dual antiplatelet therapy with ticagrelor/prasuglre

Study type

Observational

Funder types

Other

Identifiers

NCT03664388
Hospital Alvaro Cunqueiro

Details and patient eligibility

About

CardoCHUVI registry was aim to study ischemic and bleeding complication after an acute coronary syndrome (ACS), both in-hospital and follow-up events.

Full description

CardioCHUVI is a retrospective study aim to analyze all consecutively patients admitted by acute coronary syndrome to University Hospital Alvaro Cunqueiro of Vigo, between January 2010 to January 2018

The objective of the project was to study cardiac and bleeding complications, such as reinfarction, heart failure, atrial fibrillation, stroke, and bleeding events, together with all-cause and cardiac mortality

Enrollment

8,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any patient admitted to University Hospital Alvaro Cunqueiro of Vigo for acute coronary syndrome.

Exclusion criteria

  • Secondary acute coronary syndromes during a hospital admission for another cause (i.e. acute myocardial infarction in the context of a sepsis)

Trial contacts and locations

1

Loading...

Central trial contact

Sergio Raposeiras Roubín, MD, PhD; Emad Abu Assi, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems